Clinical Trial Update: Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Botulinum Toxin A for emotional stabilization in Borderline Personality Disorder has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)

Snippet

Sponsor: Hannover Medical School | Conditions: Borderline Personality Disorder | Phase 2 | Status: COMPLETED